Secondo Lastoria

5.8k total citations · 1 hit paper
159 papers, 3.5k citations indexed

About

Secondo Lastoria is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Secondo Lastoria has authored 159 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 52 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Secondo Lastoria's work include Radiopharmaceutical Chemistry and Applications (26 papers), Medical Imaging Techniques and Applications (22 papers) and Neuroendocrine Tumor Research Advances (19 papers). Secondo Lastoria is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (26 papers), Medical Imaging Techniques and Applications (22 papers) and Neuroendocrine Tumor Research Advances (19 papers). Secondo Lastoria collaborates with scholars based in Italy, United States and Malaysia. Secondo Lastoria's co-authors include Marco Salvatore, Diego Ferone, Antonella Petrillo, Luigi Frati, Ferdinando Squitieri, Gaetano Lombardi, Luigi Aloj, Andrea Ciarmiello, Annamaria Colao and Ferdinando Auricchio and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Secondo Lastoria

149 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

2024 113 citations Salvatore Tafuto, Secondo Lastoria et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Secondo Lastoria Italy	33	1.3k	991	673	639	635	159	3.5k
Andreas Schirbel Germany	35	1.4k 1.1×	885 0.9×	320 0.5×	419 0.7×	608 1.0×	106	3.1k
Ingfrid S. Haldorsen Norway	33	741 0.6×	800 0.8×	471 0.7×	308 0.5×	895 1.4×	131	3.5k
Fumiyuki Yamasaki Japan	29	496 0.4×	773 0.8×	561 0.8×	579 0.9×	375 0.6×	190	3.2k
Daniel A. Pryma United States	34	1.1k 0.8×	1.5k 1.5×	421 0.6×	541 0.8×	659 1.0×	139	3.7k
Rudolf A. Werner Germany	35	1.4k 1.1×	1.9k 1.9×	406 0.6×	766 1.2×	444 0.7×	247	4.1k
Ronald C. Walker United States	29	2.4k 1.8×	785 0.8×	398 0.6×	624 1.0×	445 0.7×	60	5.1k
Constantin Lapa Germany	44	2.4k 1.8×	2.4k 2.5×	603 0.9×	1000 1.6×	544 0.9×	284	5.9k
Stefan Rieken Germany	38	1.5k 1.1×	908 0.9×	363 0.5×	867 1.4×	992 1.6×	210	4.3k
Frank Saran United Kingdom	34	852 0.6×	964 1.0×	1.2k 1.8×	884 1.4×	827 1.3×	149	6.2k
Alexander Haug Austria	42	1.8k 1.3×	2.0k 2.0×	1.0k 1.5×	1.6k 2.5×	774 1.2×	187	4.9k

Countries citing papers authored by Secondo Lastoria

Since Specialization

Citations

This map shows the geographic impact of Secondo Lastoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Secondo Lastoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Secondo Lastoria more than expected).

Fields of papers citing papers by Secondo Lastoria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Secondo Lastoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Secondo Lastoria. The network helps show where Secondo Lastoria may publish in the future.

Co-authorship network of co-authors of Secondo Lastoria

This figure shows the co-authorship network connecting the top 25 collaborators of Secondo Lastoria. A scholar is included among the top collaborators of Secondo Lastoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Secondo Lastoria. Secondo Lastoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mauro, Annabella Di, Salvatore Tafuto, L. Cannella, et al.. (2025). A Rare Malignant Case of a Primary Pseudomyogenic Haemangioendothelioma of the Bone. Current Oncology. 32(4). 219–219. 1 indexed citations

Ionna, Franco, Corrado Aversa, Giovanni Salzano, et al.. (2024). Sentinel Lymph Node Biopsy (SLNB) for Early-Stage Head and Neck Squamous-Cell Carcinoma of the Tongue: Twenty Years of Experience at I.N.T. “G.Pascale”. Cancers. 16(6). 1153–1153. 3 indexed citations

Ottaiano, Alessandro, Alessandra Bracigliano, Francesca Di Gennaro, et al.. (2023). Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(4). 1494–1494. 13 indexed citations

Starita, Noemy, Alessandra Bracigliano, Mauro Cives, et al.. (2023). 1200P A phase II single-arm interventional trial evaluating the activity and safety of CABOzantinib (CBZ) plus TEMozolomide (TMZ) in lung and gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) progressed after SSA therapy, everolimus, sunitinib or PRRT: CABOTEM Trial. Annals of Oncology. 34. S708–S708. 1 indexed citations

Gennaro, Francesca Di, et al.. (2023). A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice. European Journal of Nuclear Medicine and Molecular Imaging. 50(6). 1753–1764. 7 indexed citations

Fazio, Nicola, Massimo Falconi, Emanuela Foglia, et al.. (2023). Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. Advances in Therapy. 41(1). 113–129. 4 indexed citations

Prosperi, Daniela, et al.. (2023). A Systematic Review on Combined [18F]FDG and 68Ga-SSA PET/CT in Pulmonary Carcinoid. Journal of Clinical Medicine. 12(11). 3719–3719. 9 indexed citations

Izzo, Francesco, Vincenza Granata, Roberta Fusco, et al.. (2021). A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Cancer. Journal of Clinical Medicine. 10(17). 4011–4011. 12 indexed citations

Capasso, Arturo, Antonio Nardone, Sandro Pignata, et al.. (2019). Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology. PLoS ONE. 14(1). e0210330–e0210330. 8 indexed citations

10.

Pecori, Biagio, Secondo Lastoria, Corradina Caracò, et al.. (2017). Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis. PLoS ONE. 12(1). e0169462–e0169462. 11 indexed citations

11.

Avallone, Antonio, Guglielmo Nasti, Gerardo Rosati, et al.. (2017). Optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC): the multicentre, randomized phase 3 study OBELICS. Annals of Oncology. 28. vi5–vi5. 1 indexed citations

12.

Granata, Vincenza, Roberta Fusco, Maria Carmela Piccirillo, et al.. (2015). Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. International Journal of Surgery. 18. 230–236. 69 indexed citations

13.

Mozzillo, Nicola, Elisabetta Pennacchioli, Sara Gandini, et al.. (2013). Sentinel Node Biopsy in Thin and Thick Melanoma. Annals of Surgical Oncology. 20(8). 2780–2786. 52 indexed citations

14.

Daponte, Antonio, Simona Signoriello, Luigi Maiorino, et al.. (2013). Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma. Journal of Translational Medicine. 11(1). 38–38. 23 indexed citations

15.

Simeone, Ester, Fabio Sandomenico, Franco Fulciniti, et al.. (2012). Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. Journal of Medical Case Reports. 6(1). 131–131. 19 indexed citations

16.

Chiofalo, Maria Grazia, Claudia Misso, Luigi Insabato, Secondo Lastoria, & Luciano Pezzullo. (2007). Hyperthyroidism due to Coexistence of Graves’ Disease and Struma Ovarii. Endocrine Practice. 13(3). 274–276. 10 indexed citations

17.

Delrio, Paolo, Antonio Avallone, Cesare Guida, et al.. (2006). Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trial.. PubMed. 4(3). S8–S8. 5 indexed citations

18.

Thomas, R., et al.. (2001). Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.. PubMed. 21(2A). 925–30. 5 indexed citations

19.

Colao, Annamaria, Secondo Lastoria, Gaetano Lombardi, et al.. (1999). Receptor imaging in the diagnosis and treatment of pituitary tumors (multiple letters) [1]. Journal of Endocrinological Investigation. 22(9). 736–737. 1 indexed citations

20.

Ferone, Diego, Secondo Lastoria, Annamaria Colao, et al.. (1998). Correlation of Scintigraphic Results Using¹²³I-Methoxybenzamide with Hormone Levels and Tumor Size Response to Quinagolide in Patients with Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 83(1). 248–252. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact